Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective episode artwork

EPISODE · May 7, 2020 · 57 MIN

Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective

from Project Medtech · host Project Medtech

In this episode, Giovanni and Sascha discuss how he became the Managing Partner at SHS, where they focus from a stage of company and geographical area, the hardline of having revenue before they invest, the major differences of going public in the US and Europe for later stage companies, the affect of EU MDR on the region and innovation, their due diligence process, and more. Sascha Alilovic LinkedIn SHS Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

Episode metadata supplied by the publisher feed · Published May 7, 2020

Embed this episode

Ready to play

Medtech Money --- Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective

0:00 57:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 57 minutes long.

When was this Project Medtech episode published?

This episode was published on May 7, 2020.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!